大涨36%蛋白降解，分子胶赛道。VAV1等合作。首付款，预付款1.2亿美金。NVS and Monte Rosa Therapeutics entered into a licensing agreement valued at up to $5.7 billion. The collaboration aims to develop drugs for immune-mediated diseases$诺华制药(NVS)$ $Monte Rosa(GLUE)$

大涨36%

蛋白降解，分子胶赛道。VAV1等合作。首付款，预付款1.2亿美金。

NVS and Monte Rosa Therapeutics entered into a licensing agreement valued at up to $5.7 billion. The collaboration aims to develop drugs for immune-mediated diseases$诺华制药(NVS)$ $Monte Rosa(GLUE)$ #Seeking# #biotech#

发布于上海